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Abstract
Background: In this study, we aim to gather information about the quality of life issues, functional
outcomes and voice problems facing early glottic cancer patients treated with the surgical
techniques such as laryngofissure cordectomy, fronto-lateral laryngectomy, or cricohyoidopexi. In
particular, consistency of life and voice quality issues with the laryngeal tissue excised during
surgery is examined. In addition, the effects of arytenoidectomy to the life and voice quality are also
studied.
Methods: 29 male patients were enrolled voluntarily in the study. The average age was 53.9 years.
Three out of 10 patients with laryngofissure cordectomy also had arytenoidectomy. 11 patients had
fronto-lateral laryngectomy with Tucker reconstruction, two of which also had arytenoidectomy.
There were eight patients with cricohyoidopexi and bilateral functional neck dissection. Three of
these patients also had arytenoidectomy. In bilateral functional neck dissection cases, spinal
accessory nerve was preserved and level V of the neck was not dissected. None of the patients had
neither radiotherapy nor voice therapy. Cordectomy patients never had a temporary tracheotomy
or were connected to a feeding tube. Data was collected for 13 months for the cordectomy group,
14 months for fronto-lateral laryngectomy and cricohyoidopexi groups on average post-
operatively. Statistical analysis in this study was carried out using the one-way analysis of variance,
and the Post-Hoc group comparisons were made after Bonferroni and Scheffé-procedures.
In order to determine the effects of arytenoidectomy, a regression analysis is carried out to see if
there are statistical differences in answers given to the survey questions among patients who were
arytenoidectomized during their surgeries.
Results: There was a statistically significant difference between cordectomy and cricohyoidopexi
group in answers to the University of Washington- Quality of Life- Revised survey part 1. (p = 0).
A statistically significant difference was also established between cordectomy and fronto-lateral
laryngectomy groups, as well as between cordectomy and cricohyoidopexi groups in answers to
the University of Washington- Quality of Life- Revised survey part 2. (p = 0,036 and p = 0.009,
respectively). Cricohyoidopexi group has given the lowest scores and the cordectomy group has
given the highest scores in three survey questions representing the quality of life, performances and
new voices. These ranges are also consistent with the laryngeal tissue excised during surgery
(cricohyoidopexi > fronto-lateral laryngectomy > cordectomy). There was no statistically
significant difference between groups in Performance Status Scale for Head and Neck cancer
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patients instrument. The difference between the Voice Handicap Index and Voice Handicap Index
(functional); Voice Handicap Index (physical) and Voice Handicap Index (emotional) scores in three
patient groups was not significant either. All of the patients evaluated that their new voices have
similar functional, physical and emotional impact on their life. Decanulation and oral feeding times
of cricohyoidopexi and fronto-lateral laryngectomy patients are found to be significantly longer
than cordectomy patients. Lastly, the removal of arytenoid does not have any significant adverse
effects on the quality of life, the functional outcomes, or the quality of voice.
Conclusion: In the present study, all patients with early glottic cancer, treated with different
surgical technics reported fairly good quality of life outcomes, functional results and voice qualities.
This study also finds that the removal of arytenoid does not have any adverse effects on the quality
of life and voice from the patients' point of view.
Background
In clinical research, QOL is recognized as an important
endpoint in addition to the traditional endpoints such as
response rate, disease-free survival, and overall survival
[1]. It is particularly relevant for patients with head and
neck cancer because social interaction and emotional
expression depend to a great extent on the structural and
functional integrity of the head and neck region [2].
Today, treatment policies are aimed to improve and main-
tain QOL during and after treatment.
Although early-stage glottic carcinomas (T1 and T2) are
currently treated with radiation therapy or endoscopic
laser resection with success, conservation laryngeal surger-
ies such as laryngofissure [C], [FLL], or [CHP] are also
available alternatives for treatment [3]. In the surgical
management of laryngeal malignancies, surgical altera-
tion or removal of the larynx affect some of the most fun-
damental life functions including airway, digestion, and
speech.
The measurement of voice quality outcomes following
treatment for laryngeal cancer is a relatively new concept.
Voice quality encompasses social, psychosocial, mental
and physical components. Given patients with same diag-
nosis and same treatment, the outcome data may be
totally different for them. Evaluation of voice quality fol-
lowing laryngeal surgery can be one of the first attempts to
assess the functional outcome following successful
treatment.
Although health-related quality of life issues in early
stages of laryngeal cancer are more important when com-
paring different therapy modalities such as surgery versus
radiation therapy, in this study we aim to gather informa-
tion about the QOL issues, functional outcomes and voice
problems facing early glottic cancer patients that were
treated with the surgical techniques mentioned above.
Results of answers provided to survey questions are com-
pared to determine whether life and voice quality issues
are consistent with the laryngeal tissue excised during sur-
gery. In addition, the effects of arytenoidectomy to the life
and voice quality are also studied.
Methods
29 male patients were enrolled voluntarily in the study.
The average age was 53.9 years. There were 10 patients
with laryngofissure [C], three of which also had (A). Two
out of 11 patients with [FLL] with Tucker reconstruction
also had (A). There were eight patients with [CHP] and
(BFND). Three of these patients also had (A). In BFND
cases, spinal accessory nerve was preserved and level V of
the neck was not dissected. Margins were checked with
frozen sections per-operatively. None of the patients had
neither radiotherapy nor voice therapy. [C] patients never
had a temporary tracheotomy nor connected to a feeding
tube. Data was collected in [C] group over 13 months,
[FLL] group over 14 months and in [CHP] group over 14
months on average post-operatively. The data on the stage
of the laryngeal cancer, the decanulation and the oral
feeding times, the surgeries applied, and the scores of the
questionnaires are listed in additional file 1. [see Addi-
tional file 1]
UW-QOL-R
The UW-QOL-R was given to all patients treated for early
glottic cancer with the above-mentioned surgeries. The
patient selects an answer from three to five choices,
depending on the question. The UW-QOL-R data were
scored on a scale of 0 to 100, with a score of 100 being
totally functional and 0 being completely incapacitated
[4]. Two small modifications have been made to increase
the sensitivity to the UW-QOL-R. First, "My speech is not
normal, but I can say all words" was added to the speech
domain. Second modification was the addition of a ques-
tion regarding the use of saliva substitutes under the saliva
domain [4].
In part 2 of UW-QOL-R, the patient answers to global
quality of life questions, selects an answer from five to sixBMC Ear, Nose and Throat Disorders 2005, 5:3 http://www.biomedcentral.com/1472-6815/5/3
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choices, ranging from very poor to outstanding, or from
much worse to much better, depending on the question.
PSS-HN
In PSS-HN, eating in public (EIP), understandability of
speech (UOS), and normalcy of diet (NOD) are each indi-
vidually assessed on a zero to 100-point scale [4].
VHI
The patients were instructed that these statements are how
many people describe their voices and the effects of their
voices on their lives. The patients marked the response
that indicates how frequently they have the same experi-
ence. 0 = Never 1 = Almost Never 2 = Sometimes 3 =
Almost Always 4 = Always.
0 to 30 = These are low scores, and indicate that most
likely there is a minimal amount of handicap associated
with the voice disorder. 31 to 60= Denotes a moderate
amount of handicap due to the voice problem. 60 to 120=
These scores represent a significant and serious amount of
handicap due to a voice problem[5].
Statistical Analysis
Statistical analysis in this study includes one-way analysis
of variance, ANOVA, and the Post-Hoc group compari-
sons after Bonferroni and Scheffé-procedures.
In order to determine the effects of arytenoidectomy, the
following regression model is adopted to see if there are
statistical differences in answers given to survey questions
among different patient groups that were arytenoidect-
omized during their surgeries.
Y = α  + β 1.CHP + β 2.FLL + β 3.A + β 4.CHP.A + β 5.FLL.A
where Y is the answer given by a patient to a question, α
is the mean of answers given by patients who had the [C]
surgery technique. [CHP] and [FLL] are dummy variables
for surgery techniques [CHP] and [FLL], respectively. The
coefficients of these variables will show the amount of dif-
ference in answers given by patients who had these tech-
niques, and those who had the [C] technique. The t
statistic of these coefficients will be used in testing
whether these differences are statistically significant or
not. Similarly, [A] is a dummy variable for patients who
had the A procedure applied after these above-mentioned
surgery techniques. Its coefficient quantifies the difference
in answers given by patients who had A procedure applied
after a surgery technique, and those who did not have. The
last two variables are interaction variables between the
[CHP] and [FLL] dummy variables, and the [A] dummy
variable. Their purpose in the model is to test whether [A]
applied after [CHP] or [FLL] leads to statistically different
answers by patients than [A] applied after [C].
Results
The regression results are given in Table 1. The effects of
the [A] procedure were different depending on the previ-
ous surgical technique applied. If applied after [CHP], the
answers of the patients to first questionnaire were gener-
ally higher, but insignificant than those of patients who
had [A] after [C]. The measures of the second and third
questions were higher too, if [A] is applied after [CHP],
rather than after [C]. These measures are also statistically
higher if [A] is applied after [FLL], rather than after [C], as
well. However, the answers to first questionnaire are
sometimes higher, sometimes lower if [A] is applied after
[FLL], rather than after [C].
The mean values for each analyzed parameter in question-
naires for three patient groups are shown on table 2. There
was a statistically significant difference between [C] and
[CHP] group in answers to the UW-QOL-R questionnaire
part 1. (p = 0). There was also a statistically significant dif-
ference between [C] and [FLL] group and [C] and [CHP]
group in answers to the UW-QOL-R questionnaire part 2.
(p = 0,036 and p = 0.009). [CHP] group have given the
lowest scores and the [C] group has given the highest
scores in three questionnaires to represent their quality of
life, performances and new voices. These ranges are also
consistent with the laryngeal tissue excised during surgery
([CHP]> [FLL]> [C]).
There was not a statistically significant difference between
groups in PSS-HN instrument. The difference between the
VHI and VHI-F, VHI-P, VHI-E scores in three patient
groups were not statistically different either (Table 3). All
of the patients evaluated that their new voices had similar
functional, physical and emotional impact on their life.
Decanulation and oral feeding times of [CHP] and [FLL]
patients has been found to be significantly longer than [C]
patients (Table 4).
Discussion
Patients generally differ in their response to cancer and to
the therapeutic interventions used in its treatment. Even
patients with a similar oncologic site and stage who
receive identical treatment can differ in their own assess-
ment of quality of life [6].
Not surprisingly, [CHP] group have given the lowest
scores and the [C] group has given the highest scores in
three questionnaires, representing their quality of life, per-
formances and new voices (Table 2). These ranges are also
consistent with the laryngeal tissue excised during surgery
([CHP]> [FLL]> [C]). A possible reason for this finding
could be that these [C] patients were never tracheot-
omized, so they were more comfortable in the postopera-
tive period. Furthermore, they were hospitalized for fewer
days, and they never had a feeding problem after the oper-BMC Ear, Nose and Throat Disorders 2005, 5:3 http://www.biomedcentral.com/1472-6815/5/3
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ation. Lastly, the most important two factors, swallowing
and communication have never been a problem for this
group. The highest score may reflect this general well-
being after the operation.
Another interesting outcome of our study is that although
the arytenoidectomized patients had longer oral feeding
and decanulation times, there are no statistically signifi-
cant effects on the quality of life, the functional outcomes,
or the quality of voice. This suggests that the more laryn-
geal tissue is removed with the exception of arytenoid, the
worse the quality of life, the functional outcomes and the
quality of voice will be. This finding further implies that
the arytenoid removal does not have an adverse effect on
the quality of life, the functional outcomes, or the quality
of voice from the patients' point of view. Removing the
arytenoid only makes the oral feeding and the decanula-
tion times longer in the first weeks after the operation, but
after the tissue heals completely and laryngeal reflexes
return to normal, larynx begins compensating arytenoid
excision, and functions satisfactorily.
UW-QOL-R
Since appearance, taste, saliva, chewing and pain are not
major issues for most early-stage glottic cancer patients,
their discussion was excluded. Swallowing is considered
important by the patients, if especially one arytenoid was
resected during surgery. Difficulty in swallowing may exist
by these patients because of aspiration risk, until the lar-
ynx adapts to this new post-surgical situation, and laryn-
geal reflexes returned to normal. The effect of
arytenoidectomy on the swallowing parameter was also
analyzed in our study, and interestingly, it is found that
the arytenoidectomy has no adverse effect on swallowing
after the patients have been discharged.
Since the improvement in swallowing, and the normalcy
of voice communication, the two major criteria for quality
of life after the laryngeal surgery [7], reflect the level of
quality of life in patients treated for laryngeal cancer, it
can be suggested again that the [CHP] group had the least
favorable quality of life after the operation among the
study groups. The significantly longer decanulation and
Table 1: Regression Results. Numbers in parentheses below the coefficients are the t statistics.
VARIABLE Constant CHP FLL A CHP.A FLL.A
Pain 82.14 -2.14 6.75 9.52 -14.52 1.59
(8.67)** (-0.15) (0.53) (0.55) (-0.58) (0.06)
Appearance 89.29 -19.29 -3.17 10.71 10.95 -9.33
(8.29)** (-1.16) (-0.22) (0.54) (0.38) (-0.31)
Activity 85.71 -15.71 -2.38 14.29 7.38 -22.62
(9.04)** (-1.07) (-0.19) (0.82) (0.29) (-0.86)
Recreation 89.29 -19.29 5.16 10.71 2.62 -55.16
(10.47)** (-1.46) (0.45) (0.69) (0.12) (-2.34) **
Swallowing 100.00 -26.60 -14.78 -11.00 26.60 9.28
(12.80)** (-2.20)** (-1.42) (-0.77) (1.28) (0.43)
Chewing 100.00 -10.00 -11.11 0.00 10.00 11.11
(16.53)** (-1.07) (-1.38) (0.00) (0.62) (0.67)
Speech 89.29 -19.29 -8.73 10.71 2.62 -3.77
(11.61)** (-1.62)* (-0.85) (0.76) (0.13) (-0.18)
Shoulder 85.71 -5.51 6.95 3.29 -5.49 -12.45
(9.34)** (-0.39) (0.57) (0.20) (-0.22) (-0.49)
Taste 95.29 -8.49 -6.40 -17.62 19.82 28.73
(11.84)** (-0.68) (-0.60) (-1.20) (0.93) (1.29)
Saliva 95.29 -8.49 -10.06 -6.29 19.49 21.06
(13.81)** (-0.79) (-1.09) (-0.50) (1.06) (1.11)
EIP 100.00 -20.00 -25.00 -33.33 53.33 58.33
(8.52)** (-1.10) (-1.60) (-1.56) (1.71)* (1.80)*
UOS 82.14 -27.14 -1.59 -32.14 68.81 39.09
(11.58)** (-2.47)** (-0.17) (-2.48)** (3.65)** (2.00)**
NOD 100.00 -4.00 -7.78 -0.00 4.00 7.78
(21.52)** (-0.56) (-1.26) (-0.00) (0.32) (0.61)
VHI 69.43 -12.43 -10.54 -6.43 8.10 15.04
(12.15)** (-1.40) (-1.38) (-0.62) (0.53) (0.95)
* denotes significance at 90% confidence level, and ** denotes significance at 95% confidence level.BMC Ear, Nose and Throat Disorders 2005, 5:3 http://www.biomedcentral.com/1472-6815/5/3
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oral feeding times, i.e. longer hospitalization, could be a
sign for a relatively worse quality of life.
PSS-HN
The measures of PSS-HN scored lower for patients who
had the [A] procedure. It could be suggested that adding
arytenoidectomy would result in lowering of the func-
tional capabilities of the patients, by statistically insignif-
icant amount though.
UOS is strongly related to voice production. The amount
of laryngeal tissue excised is highest in patients treated
Table 2: The mean values for each analyzed parameter in questionaires, decanulation and oral feeding times for 3 patient group.
C (n = 10) FLL (n = 11) CHP (n = 8)
UW-QOL-R part 1
Pain 85 91 78
Appearance 92,5 86,3 78,1
Activity 90 81,8 78,1
Recreation 92,5 86,3 75
Swallowing 96,7 84,9 79,3
Chewing 100 90,9 93,8
Speech 92,5 81,8 75
Shoulder 86,7 91 79,4
Taste 90 91 87,6
Saliva 93,4 87,9 91,8
Total score 919,3 872,9 816,1
UW-QOL-R part 2
Question 1 40 13,6 12,5
Question 2 51,7 26,8 22,8
Question 3 55,1 34,5 14
Total score 146,8 74,9 49,3
PSS-HN
Eip 90 79,5 87,5
Uos 72,5 81,8 68,8
Nod 100 93,6 97,5
Total score 262,5 254,9 253,8
VHI
VHI 67,5 60,4 57,6
VHI-f 21,8 24 20
VHI-p 22 19,7 17,1
VHI-e 23,7 16,7 20,6
Decanulation (day) 0 3,36 19,25
Oral feeding (day) 1 7,63 22,38
Table 3: Number of patient groups and VHI, VHI-F, VHI-P and VHI-E mean values and standart deviations (SD).
GROUP VHI VHI-F VHI-P VHI-E
C (n = 10) Mean (SD) 67,50 (17,34) 21,80 (5,49) 22,00 (7,45) 23,70 (9,04)
FLL (n = 11) Mean (SD) 60,45 (13,97) 24,00 (7,95) 19,73 (6,66) 16,73 (8,58)
CHP (n = 8) Mean (SD) 57,63 (10,78) 20,00 (4,14) 17,13 (5,46) 20,50 (3,74)
Table 4: Decanulation and oral feeding times (day) of the 
patients and standart deviations (SD).
Decanulation (day) 
(SD)
Oral feeding (day) 
(SD)
C (n = 7) 0 0
C + A (n = 3) 0 1
FLL (n = 9) 2,4 (0,8) 6,2 (1,3)
FLL + A (n = 2) 6,5 (0,7) 13 (1,4)
CHP (n = 5) 18,2 (1,9) 20,6 (2,0)
CHP + A (n = 3) 21,3 (0,5) 24,6 (1,1)BMC Ear, Nose and Throat Disorders 2005, 5:3 http://www.biomedcentral.com/1472-6815/5/3
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with [CHP] and as expected, the VHI is lowest in these
patients. The lowest scores for UOS were given to the
[CHP] patients, and as expected, the UOS score is signifi-
cantly lower in the [CHP] group.
VHI
Vocal results after [C] and [FLL] could be unsatisfactory,
since there is a gap in the creation of a new glottis due to
removal of a considerable mass of tissue. After [CHP], the
results could be much worse, since both the vocal folds
were excised and a neoglottis formation is anticipated.
Although statistically insignificant, the [CHP] patient
group had given the lowest VHI scores in assessing their
new voices in our study. In all of the patient groups, the
quality of voice was found to be sufficient to hold a nor-
mal individual conversation. However, the voice was
defined by the patients as hoarse and dull. It was rated to
be insufficient to make a conversation in a noisy atmos-
phere, since it can not be raised satisfactorily. It also
should be remembered that all patients with laryngeal
malignancies had voice and communication problems at
diagnosis.
Many authors have also studied the quality of voice fol-
lowing radiation therapy for T1 and T2 glottic cancers.
Traditionally, radiation therapy has been advocated over
surgery by many authors because of the belief that voice
quality is superior in the radiation therapy cohort. A
review of the literature shows a wide variation in findings
[8-15].
The measures VHI questionnaire scored lower for patients
who had the [A] procedure. It could be hypothesized that
the addition of arytenoidectomy would result in increases
in voice handicap of the patients, though statistically
insignificant.
Conclusion
In the present study, all patients with early glottic cancer,
treated with different surgical techniques reported fairly
good QOL outcomes, functional results and voice quali-
ties. The results of this study also imply that the removal
of arytenoid does not have any statistically significant
adverse effects on the quality of life, the functional out-




[FLL] = Fronto-lateral laryngectomy
[CHP] = Cricohyoidopexi
[A] = Arytenoidectomy
[BFND] = Bilateral functional neck dissection
[QOL] = Quality of life
[UW-QOL-R] = University of Washington- Quality of Life-
Revised
[PSS-HN] = Performance Status Scale for Head and Neck
cancer patients
[EIP] = Eating in public
[UOS] = Understandability of speech
[NOD] = Normalcy of diet
[VHI] = Voice Handicap Index
[VHI-F] = Voice Handicap Index, functional
[VHI-P] = Voice Handicap Index, physical
[VHI-E] = Voice Handicap Index, emotional
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